Oxygenta Pharmaceutical Q3 Results

  • BSE: 524636
  • NSE: -
  • ISIN: INE102E01018
  • Sector: Biotechnology & Drugs
BSE
74.81.70 (2.33%)
Volume16.27 K
Updated: Mon 25 Nov, 2024 | 15:29:21
NSE
This stock is not traded on NSE
Today: 73.21
76.68
52-Wk: 26.01
108.64

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Oxygenta Pharmaceutical Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 9.1513.08-%7.85-%
    Selling/ General/ Admin Expenses Total 0.240.33-%0.27-%
    Depreciation/ Amortization 0.690.83-%0.40-%
    Other Operating Expenses Total -0.00--%--%
    Total Operating Expense 12.0115.72-%10.50-%
    Operating Income -2.86-2.64-%-2.64-%
    Net Income Before Taxes -3.55-3.18-%-3.25-%
    Net Income -3.78-3.16-%-3.25-%
    Diluted Normalized EPS -1.11-0.86-%-2.05-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts